INTRODUCTION
Helicobacter pylori infection is a well-known etiologic factor in the development of stomach cancer and gastric mucosal-associated lymphoid tissue lymphoma.
1 H. pylori infection has been epidemiologically linked to cardiovascular and cerebrovascular disease, and even to extragastric malignancies such as liver or colon cancer. [2] [3] [4] The causal relationship between H. pylori and colorectal neoplasms have not been clarified. Chronic H. pylori infection leads to gastric atrophy and hypochlorhydria, resulting in an increase in plasma gastrin levels. The resulting hypergastrinemia may play a role in the development of colon cancer in in vitro and in vivo models but currently published reports are conflicting. [5] [6] [7] [8] [9] [10] Recent publications have reported a positive association between H. pylori infection and colon cancer, [11] [12] [13] [14] [15] but these findings are controversial as other researchers did not identify any association between colorectal neoplasms and H. pylori infec-
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The Korean Journal of Gastroenterology tion. [16] [17] [18] The prevalence of colorectal cancer has rapidly increased in Korea, and it is now the third most common malignancy after gastric and lung cancers. As the prevalence of H. pylori infection in Korea is reported to be about 60%, 19 it is important to determine whether this is a risk factor for colorectal cancer.
If there is a significant association between H. pylori infection and colon cancer, it will help identify high-risk groups for colorectal cancer screening.
The objective of this study was to determine whether H. pylori IgG seropositivity was associated with pathologically confirmed colorectal neoplasms in Korean subjects undergoing a routine checkup.
SUBJECTS AND METHODS

Patients
This study was carried out by retrospectively analyzing the data of 10,082 subjects who had had a routine checkup at 
Ethics
This study was carried out with the approval of the hospital's institutional review board (KC10RISI0392).
Statistical analysis
The H. pylori IgG seropositivity was defined as ≥10.0 U/mL.
We excluded one subject who failed to have a complete colonoscopy. H. pylori seropositivity was determined in subjects with colon cancer and advanced adenomas which was defined as adenomas at least 10 mm in diameter, having high grade dysplasia, villous or tubullovillous pathology or any combination of the above. The remaining subjects were designated as our control group. The frequency of H. pylori seropositivity was compared between subjects with colorectal neoplasms and controls by independent t-test and χ 2 tests.
Logistic regression analysis was used to obtain the OR and 95% CI of colorectal neoplasms according to H. pylori IgG seropositivity. A p-value less than 0.05 was considered to be statistically significant.
RESULTS
A total of 10,082 subjects elected to have a routine checkup during the study period. Of these, colonoscopy was done in 150 participants due to positive stool occult blood test and 65 due to positive DCBE. The remaining 383 participants decided on elective colonoscopy regardless of stool occult blood test or DCBE results. Total of 598 underwent colonoscopy and only one subject failed to complete the study.
There were 335 H. pylori-positive subjects and 262 who were H. pylori-negative. There were no significant differences in age, sex, BMI, HbA1c or total cholesterol levels between the two groups. Though the data for smoking, alcohol, medication, previous medical history and family history were recorded, not all data was available and thus were not evaluated. Colonoscopic diagnosis of 9 cases of carcinoma and 172 cases of colorectal polyps were made, and histological confirmation revealed 9 cases of adenocarcinoma and 118 cases of colorectal adenoma (Table 1) . Twenty one cases of DCBE were done in the case group and 19 turned out to be positive, while only 8 cases of stool occult blood tests were positive. Values are presented as mean±SD or n (%). sitivity was higher in subjects with colorectal neoplasms than in the controls, particularly for patients with colorectal adenoma and multiple adenomas (≥3). 
DISCUSSION
In this study, we found a positive association between colorectal neoplasms and H. pylori infection in subjects undergoing routine checkups. The prevalence of seropositivity was significantly higher in subjects with adenomas than in subjects with normal colonoscopic findings. Positive association was not found in cancer patients because of the limited numbers. The risk increase was found to be greater in neoplasms located in the distal colon.
The strength of this study was that participants were selected from a relatively large number of subjects undergoing routine checkup who were asymptomatic. The overall prevalence of H. pylori and the incidence of colorectal neoplasms in our study population were similar to those reported recently in Korea. 20, 21 We selected the control subjects from the same study population that produced the cases to eliminate socioeconomic and other potential background differences and to maximize the representativeness of the controls.
Two pertinent meta-analyses combining the results of 11 studies and 13 studies yielded summary ORs of 1.4 (95% CI 26 In a Japanese study of 332 routine checkup subjects, a significant increase in the incidence of adenomatous polyps and decrease in normal colonoscopic findings were observed in seropositive patients compared with seronegative individuals. 15 Another Japanese study of 669 hospital patients also demonstrated a positive association of colorectal neoplasms with H. pylori (OR 1.66), specially higher risk in female patients. 27 In addition, a population-based case-control study of 239 asymptomatic Japanese male adenoma patients with 239 adenoma-free controls showed that H. pylori infection was a risk factor for adenoma (OR 2.26) as a whole and that this risk was enhanced by the presence of chronic atrophic gastritis, especially in the proximal colon. 28 To summarize, these East Asian studies support the association of H. pylori infection with the formation of colorectal neoplasms.
The causal relationship between H. pylori and colorectal neoplasms have not been clarified. Chronic H. pylori infection leads to gastric atrophy and hypochlorhydria, resulting in an increase in plasma gastrin levels. Gastrin is known to induce higher mucosal cell proliferation in the colon. 7 It is expressed by colorectal cell lines and by primary colon cancer and its receptors are increased. 8, 9 Also, gastrin has been reported as a potent mitogen capable of inducing cyclooxygenase-210, which leads to prostaglandin E2 production, 29 which may contribute to colon carcinogenesis.
Our study found that the risk increase was greater for neoplasms located in the distal colon. This is supported by a recent large case-control study which found that the risk for colorectal cancer was increased in the distal colon. 24 Animal studies have suggested that the mitogenic effect of gastrin are limited to the distal colon. 7, 30 Also, a case-control study on hypergastrinemia and colorectal adenoma found an increased risk for only distal colon adenoma 31 while a prospective study found that elevated gastrin levels were more associated with rectal cancer than colon cancer. 12 These findings are consistent with our study and may explain why neoplasms in the distal colon were showed higher risk in- as the routine check-ups were done 10 years before this analysis, it may not accurately depict the current rates of H. pylori infection and colorectal neoplasm prevalence.
In conclusion, our study supports the finding that H. pylori infection is associated with an increased risk of colorectal adenoma, and is consistent with several East Asian studies.
There is also a small but relevant risk increase for colorectal neoplasm formation, especially in the distal colon. Further study is needed whether colorectal surveillance is effective in H. pylori-infected gastric cancer patients before gastrectomy. Further investigation into the role of H. pylori infection in carcinogenesis of the colon is necessary, and studies on whether H. pylori eradication reduces the incidence of colorectal neoplasm need to be performed.
